Literature DB >> 2494259

Mast cell chymase. A potent secretagogue for airway gland serous cells.

C P Sommerhoff1, G H Caughey, W E Finkbeiner, S C Lazarus, C B Basbaum, J A Nadel.   

Abstract

Submucosal glands are the major sources of airway secretions in most mammals. Mast cells are abundant in the environment of airway submucosal glands and are rich sources of secreted proteases. To investigate the hypothesis that mast cell proteases stimulate airway gland secretion, we studied the ability of the two major mast cell granule proteases, chymase and tryptase, to cause secretion of 35S-labeled macromolecules from a line of cultured bovine airway gland serous cells. Mast cell chymase and tryptase were purified from dog mastocytoma cells. Chymase markedly stimulated serous cell secretion in a concentration-dependent fashion with a threshold of 10(-10) M, whereas tryptase had no effect. The response to 10(-8) M chymase (1530 +/- 80% over base line) was approximately 10-fold higher than that evoked by other agonists such as histamine and isoproterenol. The predominant 35S-labeled macromolecule released by chymase was chondroitin sulfate proteoglycan, the glycoconjugate present in serous cell secretory granules. The response to chymase was non-cytotoxic and was blocked by active site inhibitors of chymase (soybean trypsin inhibitor and chymostatin) and by inhibitors of cellular energy metabolism (azide,2,4-dinitrophenol, dicumarol). Supernatant obtained by degranulation of mastocytoma cells caused a secretory response of comparable magnitude to that caused by chymase. These findings demonstrate that chymase, but not tryptase, is a potent secretagogue for airway gland serous cells, and they suggest a possible role for chymase-containing mast cells in the pathogenesis of airway hypersecretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494259

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  The diverse effects of mast cell mediators.

Authors:  Colleen Hines
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma.

Authors:  Ryan H Dougherty; Sukhvinder S Sidhu; Kavita Raman; Margaret Solon; Owen D Solberg; George H Caughey; Prescott G Woodruff; John V Fahy
Journal:  J Allergy Clin Immunol       Date:  2010-05       Impact factor: 10.793

3.  Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2012-04-24       Impact factor: 10.793

Review 4.  Mast cell tryptases and chymases in inflammation and host defense.

Authors:  George H Caughey
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

5.  Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells.

Authors:  C P Sommerhoff; J A Nadel; C B Basbaum; G H Caughey
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung.

Authors:  P R Butchers; C J Vardey; M Johnson
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

Review 7.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

8.  Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4.

Authors:  T Yoshikawa; T Imada; H Nakakubo; N Nakamura; K Naito
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

9.  Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Authors:  M J Gizycki; K L Hattotuwa; N Barnes; P K Jeffery
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 10.  Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease.

Authors:  R Polosa; S Rorke; S T Holgate
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.